Mucoadhesive systems in dentistry: A review

  • Authors

    • Rishi Rath ITS Dental College,MuradnagarGhaziabad-201206
    • Siddharth Tevatia ITS Dental College,Muradnagar,Ghaziabad-201206
    • Anukriti Rath ITS Dental College,Muradnagar,Ghaziabad-201206
    • Ashish Behl ITS Dental College,Muradnagar,Ghaziabad-201206
    • Vishal Modgil ITS Dental College,Muradnagar,Ghaziabad-201206
    • Nikhil Sharma ITS Dental College,Muradnagar,Ghaziabad-201206
  • Adhesion, bioadhesive, localdrugdelivery, mucoadhesive, vehicle
  • For any treatment plan to succeed, two factors are paramount correct selection and application of pharmacologic agents and patient compliance. But what happens when both these are followed judiciously, but the medicine itself does not stay long enough to finish its action? Then we need something that will make the medicine stick literally. That is when bioadhesives have their say. Long-term adhesion of drugs to the oral mucosa is usually prevented by the continuous salivary flow and the mechanical movements of the tongue. Therefore, formulations acting as vehicle for local drug delivery to the oral mucosa need to have excellent mucoadhesive properties. The present article reviews mucoadhesive systems with various formulations that can be used in dentistry to improve local drug delivery.

  • References

    1. [1] Amir H. Shojaei. Buccal Mucosa - As A Route for Systemic Drug' Delivery: A Review. J Pharm PharmaceutSci (—csps); 1(1):15-30, 1998.

      [2] Anders R and Merkle H. Evaluation of laminated mucoadhesive patches for buccal drug delivery. Int. J. Pharm. 1989; 49:231-240.

      [3] Barsuhn C.L, Olanoff L.S, Gleason D.D, AdkinsE.L, Ho, N.F. Human buccal absorption of flurbiprofen. Clin. Pharmacol. Then 1988; 44:225-231.

      [4] Bhaskara J, Xiaoling L and Gary C. Recent Advances in mucoadhesive drug delivery systems. In Drug Delivery: Polymers-Business Briefing: Pharmatech. pp: 194-196, 2003.

      [5] Jadhav B, Khandelwal K, Ketkar A, Pisal S. Formulation and evaluation of mucoadhesive tablets containing eugenol for the treatment of periodontal diseases. Drug Development and Industrial Pharmacy. 2004 Dec; 30 (2):195-203.

      [6] Mizrahi B, Golenser J, Wolnerman J, Domb A: Adhesive tablet effective for treating canker sores in humans. Journal of Pharmaceutical Sciences.2004 ;( 93):2927-2935.

      [7] Bottenberg P, Bultmann C, GrAnber HG. Distribution of fluoride in the oral cavity after application of a bioadhesive fluoride-releasing ablct. J Dent Res. 1998 Jan; 77(1):68-72.

      [8] Bremecker K, Strempe H and Klein G. Novel concept for a mucosal adhesive ointment. J Pharm Sci. 1984; 73:548-552.

      [9] Bromberg LE, Braman VM, Rothstein DM et al. Sustained release of silver from peridontal wafers for the treatment of periodontitis. J. Control Release. 2000; 68:63-77.

      [10] Carr MP and Horton JE. Evaluation of a transoral delivery system for topical anesthesia. J Am Dent Assoc. 2001 Dec; 132(12):1714-9.

      [11] Chen W-G and Hwang GC-C. Adhesive and in vitro release characteristics of propranolol bioadhesive disc system. Int J Pharm 1992; 82(1-2):61-66.

      [12] Collins A.E and Deasy P.B, Bio-adhesive lozent2e for the improved delivery of cetylpyridinium chloride. J. Pharm. Sci.1990:79:116-119.

      [13] Collins A.E, Deasy P.B, Mac Carthy D.J. and Shanley D.B. Evaluation of a controlled release compact containing tetracycline hydrochloride bonded to tooth for the treatment of periodontal disease. Int. J. Pharm. 1989; 51:103-114.

      [14] David J, Woolfson A, Brown A and Neill M. J Control Release. 1997 Nov; 49 (1):71-79.

      [15] Davis S.S, Daly P.B, Kennerley J.W, Frier M, Hardy J.G. and Wilson C.G. Design and Evaluation of Sustained Release Formulations for Oral and Buccal Administration, In: Bussmann, Dries, R.R. and Wagner, W. (eds), Controlled Release formance. Int J Pharm 1999; 177(2):201-209.

      [16] Decker EM, Von Ohle C, Weiger R, Wiech I, Brecx M. A synergistic chlorhexidine/chitosan combination for improved antiplaque strategies. J Periodontal Res. 2005; oct; 40(5):373-377.

      [17] Elkayam R, Friedman M, Stabholz A, Soskolne A, Sela M.N and GolubL.Sustained release device containing minocycline for local treatment of periodontal disease. J Control. Rel 1988; 7:231-236.

      [18] Epstein JB, Truelove EL. Topical cyclosporine in a bioadhesive for treatment of oral lichenoid mucosal reactions: an open label clinical trial. Oral Surg Oral Med Oral Pathol Oral RadiolEndod. 1996 Nov; 82(5):532-6.

      [19] Frechoso SC, MenA©ndez M, Guisasola C, Arregui I, Tejerina JM, Sicilia A. Evaluation of the efficacy of two potassium ritratebioadhesive gels (5% and 10%) in the treatment of dentinehypersentivity. A randomized clinical trial. J ClinPeriodontol 2003.30(4):315-320.

      [20] Galey WR, Lonsdale HK, Nacht S. the in vitro permeability of skin and buccal mucosa to selecteddrugs and tritiated water. J Invest. Dermatol.1976; 67:713-717.

      [21] Gandhi R and Robinson J. Oral cavity as a site for bioadhesive drug delivery. Adv. Drug Del. Rev. 1994; 13:43-74.

      [22] Guo G H. Bioadhesive polymer buccal patches for buprenorphine controlled delivery: Formulation in vitro adhesion and release properties. Drug DevInd Pharmacy. 1994; 20:2819-2821.

      [23] Han. RY, Fang JY, Sung KC, Hu OYP. Mucoadhesivebuccal disks for novel nalbuphine formulation prodrugontrolled delivery: Effect of variables on drug release and mucoadhesive per-formance. Int J Pharm 1999; 77(2):201-209.

      [24] Hannah Batchelor. Novel Bioadhesive formulations in drug delivery. In: The drug delivery companies report autumn winter 2004. pp. 16-18.

      [25] Harris D, Robinson J.R. Drug delivery via the mucous membranes of the oral cavity. J. Pharm. Sci. 1992; 81:1-10.

      [26] Hita-Iglesias P, Torres-Lagares D, Flores-Ruiz R, Magallanes-Abad N, Effectiveness of chlorhexidine gel versus chlorhexidine rinse in reducing alveolar osteitis in mandibular third molar surgery. J Oral Maxillofac Surg. 2008 Mar; 66(3):441-5.

      [27] Ishida M, Nambu N. and Nagai T. Highly viscous gel ointment containing Carbopol for application to the oral mucosa. Chem Pharm Bull.1983; 31:4561-4564.

      [28] Ishida M, Nambu N, and Nagai T. Mucosal dosage form of ocaine for toothache using hydroxypropyl cellulose and carbopol, Chem. Pharm. Bull.1982;30:980-984.

      [29] John D Smart. The basics and underlying mechanism of mucoadhesion-mucoadhesve Polymers: Strategies, Acheivements and Future Challenges. 2005; Vol 57(11).

      [30] Irache J, Maria Huici, Monica Konecny, Socorro Espuelas, Miguel. Angel Campanero and Pau Arbos. Bioadhesive Properties of Gantrez Nanoparticles. Molecules 2005; 10:126-145.

      [31] Kohda, Y., Kobayashi, H., Baba, Y., Yuasa, H..Ozeki, T., Kanaya, Y and Sagara, E., Controlled release of lidocaine from buccal mucosa-adhesive films with solid dispersion. Int J Pharm. 1997; 158:147-155.

      [32] KokKhiangPeh, Choy Fun Wong. Polymeric Films as Vehicle for Buccal Delivery: Swelling, Mechanical, and Bioadhesive Properties. J Pharm PharmaceutSci ( 1999.2(2):53-61.

      [33] Kutcher M, Ludlow M, Samuelson A, Campbell T, Pusek T. Evaluation of a bioadhesive device for the management of aphthous ulcers. JADA, March 2001; 132:368-76.

      [34] Michael U Adikwu. Mucins and their potentials. Tropical Journal of Pharmaceutical Research. 2006 Dec; 5(2):581-582.

      [35] Petelin M, Pavlica Z, Bizimoska S, Sentjurc M. In vivo study of different ointments for drug delivery mucosa by EPR oximetry. International Journal of Pharmaceutics. 2004; 270: 83-91.

      [36] Castionis N, Baehni P and Gurny R. Current status in oral fluoride pharmacokinetics and implications for prophylaxis against European Journal of Pharmaceutics Biopharmaceutics. 1998 Mar; 45(2):101-111.

      [37] Nagai T, Machida .Advances in drug delivery: Mucosal adhesive dosage forms. Pharm Int 1985; 6(8):196-200.

      [38] Nagai T, Machida Y. Buccal delivery systems using hydrogels. Adv Drug Delivery Rev 1993; 11(1-2):179-191.

      [39] Nagai T.Adhesive topical drug delivery system, J. Control. Rel. 1985; 2:121-134.

      [40] Needleman IG, Smales FC, Martin GP. An investigation of caries and bioadhesion for periodontal and oral mucosal drug delivery. J ClinPeriodontol. 1997 Jun; 24(6):394-400.

      [41] Noordzij JP, Foresman PA, Rodeheaver GT, Quinn JV, Edlich RF. Tissue adhesive wound repair revisited. J Emerg Med 1994; 12:645-9.

      [42] Park H and Robinson JR. Mechanisms of mucoadhesion of poly (acrylic acid) hydrogels, Pharm. Res. 1987; 4:457-464.

      [43] Park CR, Munday DL. Development and evaluation of a b phasic buccal adhesive tablet for nicotine replacement therapy. Int J Pharm 2002; 237(1-2):215-226.

      [44] Pimlott S.J, Addy M. A study into the mucosal absorption of osorbidedinitrate at different intraoral sites. Oral. Surg, Oral. Med. Oral. Pathol. 1985; 59:145-148.

      [45] Quinn Drzewiecki AE, Li MM, et al. A randomized, controlled a tissue adhesive with suturing in the re air of p pediatric facial lacerations. Ann Emerg Med 1993; 9:1130-5.

      [46] Samaranayake L and Ferguson M. Delivery of antifunQa1 agents to the oral cavity, Adv. Drug Del. Rev. 1994; 13:161-179.

      [47] Satoh K, Takayama K, Machida Y, Suzuki Y, Nakagaki M. Nagai T. Factors affecting the bioadhesive property of tablets consistingof hydroxypropyl cellulose and carboxyvinyl polymer. Bull 1989; 37(5):1366-1368.

      [48] Schor J.M, Davis S.S, Nigalaye A and Bolton S. Sudarintransmucosal tablets. Drug DevInd Pharmacy.1983; 9:1359-1377.

      [49] Scrivener CA, Schantz CW. J Am Dental Assoc. 1947; 35:644-647.

      [50] Senel S, Hincal AA. Drug permeation enhancement via buccal route: Possibilities and limitations. J Controlled Release 2001; 72(1-3):133-144.

      [51] Squier CA and Hall BK. The permeability of mammalian non-keratinized oral epithelia to horse radish peroxidase applied in vivo and in vitro, Arch. Ural Biol., 29:45-50, 1984.

      [52] Squier C.A. and Wertz P.W. Structure and function of the oral mucosa and implications for drug delivery, In M.J. Rathbone (ed.), Oral mucosal Drug Delivery, Marcel Dekker, Inc., New York, New 26,1996.

      [53] Squier C.A, Cox P, and Wertz P.W. Lipid content and water permeability of skin and oral mucosa. The J. Invest. Dermat. 1991; 96: 123-126,

      [54] Stephen E, Hardingt S.S, Deacon M andFiebrig I. Biopolymer Mucoadhesive biotechnology and Genetic Engineering Reviews. Vol. 16, April, 1999.

      [55] Sveinsson. S.J. and Holbrook, P.W., Oral' mucosa adhesive ointment containing, liposomal corticosteroid. Int J Pharm. 1993: 95:105-109.

      [56] Taware CP, Mazumdar S, Pendharkar M, Adani MH, Devarajan PV. A bioadhesive delivery system as an alternative to infiltration anesthesia. Oral Surg Oral Med Oral Pathol Oral RadiolEndod. 1997 Dec; 84(6):609-15.

      [57] Wertz P.W and Squier C.A. Cellular and molecular basis of barrier function in oral epithelium, Crit. Sys.1991, 8:237-269.

      [58] Wong C.F, Yuen K.H and Peh K.K., Formulation and evaluation of controlled release Eudragitbuccal patches. Int J Phartn.19q: J78:11-22.

      [59] Wodley J. bioadhesion: New possibilities for drug administration. 2001; 40 (2):77-84.

  • Downloads

  • How to Cite

    Rath, R., Tevatia, S., Rath, A., Behl, A., Modgil, V., & Sharma, N. (2016). Mucoadhesive systems in dentistry: A review. International Journal of Dental Research, 4(2), 25-29.